FDA Inspection 960815 — Biomat USA, Inc

Biomat USA, Inc — FEI 1643256

The FDA completed an inspection of Biomat USA, Inc on January 13, 2016 in McAllen, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 13, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
McAllen, TX (United States)